Nucleocapsid protein of human immunodeficiency virus as a model protein with chaperoning functions and as a target for antiviral drugs.
about
Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production.Analysis of hepatitis C virus RNA dimerization and core-RNA interactionsThe HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitroNatural and pharmacological regulation of telomeraseDistinct nucleic acid interaction properties of HIV-1 nucleocapsid protein precursor NCp15 explain reduced viral infectivity.Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein.Ty3 integrase is required for initiation of reverse transcriptionProline residues within spacer peptide p1 are important for human immunodeficiency virus type 1 infectivity, protein processing, and genomic RNA dimer stability.MoMuLV and HIV-1 nucleocapsid proteins have a common role in genomic RNA packaging but different in late reverse transcription.Single aromatic residue location alters nucleic acid binding and chaperone function of FIV nucleocapsid protein.The Interaction between tRNA(Lys) 3 and the primer activation signal deciphered by NMR spectroscopy.Characterization of a nucleocapsid-like region and of two distinct primer tRNALys,2 binding sites in the endogenous retrovirus Gypsy.Crystal structure of an antiviral ankyrin targeting the HIV-1 capsid and molecular modeling of the ankyrin-capsid complex.Investigating the cellular distribution and interactions of HIV-1 nucleocapsid protein by quantitative fluorescence microscopy.Intracellular HIV-1 Gag localization is impaired by mutations in the nucleocapsid zinc fingers.Virion packaging determinants and reverse transcription of SRP RNA in HIV-1 particles.Site-selective probing of cTAR destabilization highlights the necessary plasticity of the HIV-1 nucleocapsid protein to chaperone the first strand transfer.Nucleocapsid protein function in early infection processes.The N-terminal zinc finger and flanking basic domains represent the minimal region of the human immunodeficiency virus type-1 nucleocapsid protein for targeting chaperone function.Rubella virus capsid protein: a small protein with big functions.Implications of the nucleocapsid and the microenvironment in retroviral reverse transcription.Specific implications of the HIV-1 nucleocapsid zinc fingers in the annealing of the primer binding site complementary sequences during the obligatory plus strand transfer.The fragile X mental retardation protein has nucleic acid chaperone properties.A 5'-3' long-range interaction in Ty1 RNA controls its reverse transcription and retrotransposition.The conserved N-terminal basic residues and zinc-finger motifs of HIV-1 nucleocapsid restrict the viral cDNA synthesis during virus formation and maturation.Nucleocapsid mutations turn HIV-1 into a DNA-containing virus.The hepatitis C virus Core protein is a potent nucleic acid chaperone that directs dimerization of the viral (+) strand RNA in vitro.Probing dynamics of HIV-1 nucleocapsid protein/target hexanucleotide complexes by 2-aminopurineEffects of the nature and concentration of salt on the interaction of the HIV-1 nucleocapsid protein with SL3 RNA.Alpha-helicoidal HEAT-like Repeat Proteins (αRep) Selected as Interactors of HIV-1 Nucleocapsid Negatively Interfere with Viral Genome Packaging and Virus Maturation.Nucleotide excision repair and template-independent addition by HIV-1 reverse transcriptase in the presence of nucleocapsid protein.
P2860
Q21245209-928B334D-6CEE-4998-9568-0C5742EBDEA3Q27473200-A013E130-F95C-478C-9FD8-D9E1F812BE77Q27486255-A630FB29-CD85-4204-8B8A-7551C49DF606Q31038583-367BD37C-DC75-4660-9362-ADAD26C4E33CQ33791156-ADD39AAE-4ED8-42E1-9AD1-8D07838A3358Q34163977-0D5497B8-148A-4953-BED2-1B867FBE17CBQ34332190-5E502D19-E931-489E-B3FE-6530C87710CFQ34354549-5EB8055E-6CB8-4E19-A3BF-6333E12DE877Q34511074-AEC26674-5670-4480-B96F-057CFB466B04Q34614790-E4BEFB7B-5CD6-4395-85CA-D520FDD059C7Q34769447-D2FC6656-7F84-402E-A9B0-63A514F42B41Q35128110-151D2B40-5365-4C44-8086-24F0660EF40EQ35201628-1C40660E-90B0-4297-84AB-4907232DD74FQ35568826-C0632933-DFDA-45F6-A3CE-52DD8B1BD618Q35990587-6A7361BF-5C8D-48FB-8019-A75DC95093F8Q36329001-36B682F8-C178-45DE-B8D6-F4992D6BAFB7Q36814171-DDD86D5F-3D50-4DE0-A762-87693242F76AQ37086413-B58FBC88-EFE9-4977-9D67-1102CB483D25Q37419637-5CC0572E-4CB6-4C61-86CE-8DDC925D3C69Q37721412-924FC6DB-75B2-4B4C-BEB7-74178A1E7108Q37945202-98E4B948-923F-4BAC-AB0C-8599FC19623CQ38335419-67DBEAFB-9D22-431E-BA82-63A923F910B4Q38342235-E7F57FA9-47CF-41AB-B5F0-80DB61F0BD4EQ39647913-5CCFBADB-2EB1-4BDF-BE0D-74DBEB9037D2Q39959233-4B249268-F37F-47AB-86BB-31DDCC361E8CQ40009476-8DD44C7A-8E57-4792-9B25-3E56C3CD518AQ40899915-DA3BBEF0-853E-435E-969D-F00342911743Q42077951-7067EC39-2EF2-43F2-B007-8D89EC94E796Q42117302-EC879B52-BF52-4DFA-9AB6-B86B2B378F12Q45324180-F0153EFC-DE61-4797-BE37-F3509045CE1FQ46962949-2C397ECD-A4DE-4E7B-B1F6-D40C1782D4CD
P2860
Nucleocapsid protein of human immunodeficiency virus as a model protein with chaperoning functions and as a target for antiviral drugs.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Nucleocapsid protein of human ...... a target for antiviral drugs.
@ast
Nucleocapsid protein of human ...... a target for antiviral drugs.
@en
Nucleocapsid protein of human ...... a target for antiviral drugs.
@nl
type
label
Nucleocapsid protein of human ...... a target for antiviral drugs.
@ast
Nucleocapsid protein of human ...... a target for antiviral drugs.
@en
Nucleocapsid protein of human ...... a target for antiviral drugs.
@nl
prefLabel
Nucleocapsid protein of human ...... a target for antiviral drugs.
@ast
Nucleocapsid protein of human ...... a target for antiviral drugs.
@en
Nucleocapsid protein of human ...... a target for antiviral drugs.
@nl
P2093
P1476
Nucleocapsid protein of human ...... a target for antiviral drugs.
@en
P2093
P304
P356
10.1016/S1054-3589(00)48011-7
P577
2000-01-01T00:00:00Z